Nanoformulation development to improve the biopharmaceutical properties of fisetin using design of experiment approach

Abstract

This study aimed to design an effective nanoparticle‐based carrier for the oral delivery of fisetin (FST) with improved biopharmaceutical properties. FST‐loaded nanoparticles were prepared with polyvinyl alcohol (PVA) and poly(lactic‐co‐glycolic acid) (PLGA) by the interfacial deposition method. A central composite design of two independent variables, the concentration of PVA and the amount of PLGA, was applied for the optimization of the preparative parameter. The responses, including average particle size, polydispersity index, encapsulation efficiency, and zeta potential, were assessed. The optimized formulation possessed a mean particle size of 187.9 nm, the polydis-persity index of 0.121, encapsulation efficiency of 79.3%, and zeta potential of −29.2 mV. The morphological observation demonstrated a globular shape for particles. Differential scanning calorime-try and powder X‐ray diffraction studies confirmed that the encapsulated FST was presented as the amorphous state. The dissolution test indicated a 3.06‐fold increase for the accumulating concentra-tions, and the everted gut sac test showed a 4.9‐fold gain for permeability at the duodenum region. In conclusion, the optimized FST‐loaded nanoparticle formulation in this work can be developed as an efficient oral delivery system of FST to improve its biopharmaceutic properties.